{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:54:05Z","timestamp":1743267245872},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,24]]},"DOI":"10.7759\/cureus.63009","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T07:46:29Z","timestamp":1719215189000},"source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Cost of Living on the Quality of Life of Cystic Fibrosis Patients: A Study in Greece"],"prefix":"10.7759","author":[{"given":"Dimitris","family":"Dainavas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantelis","family":"Stergiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Manthou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Lioliousis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filia","family":"Diamantea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavlos","family":"Myrianthefs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Fildissis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak SG","year":"2020","unstructured":"Kapnadak SG, Dimango E, Hadjiliadis D, et al.. Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease. J Cyst Fibros. 2020, 19:344-354. 10.1016\/j.jcf.2020.02.015","journal-title":"J Cyst Fibros"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell PM","year":"2008","unstructured":"Farrell PM, Rosenstein BJ, White TB, et al.. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008, 153:S4-S14. 10.1016\/j.jpeds.2008.05.005","journal-title":"J Pediatr"},{"key":"ref3","unstructured":"World Health Organisation. Programme on mental health. WHOQOL-\r\nmeasuring quality of life. (2024). Accessed: June 23, 2024: http:\/\/www.who.int\/mental_health\/media\/68.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-832485","article-title":"Quality of life with cystic fibrosis--aspects of age and gender [Article in German]","volume":"218","author":"Schmitz TG","year":"2006","unstructured":"Schmitz TG, Henrich G, Goldbeck L. Quality of life with cystic fibrosis--aspects of age and gender [Article in German]. Klin Padiatr. 2006, 218:7-12. 10.1055\/s-2004-832485","journal-title":"Klin Padiatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(03)00093-6","article-title":"Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity","volume":"2","author":"Gee L","year":"2003","unstructured":"Gee L, Abbott J, Conway SP, Etherington C, Webb AK. Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity. J Cyst Fibros. 2003, 2:206-213. 10.1016\/S1569-1993(03)00093-6","journal-title":"J Cyst Fibros"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2004.12.005","article-title":"Associations between clinical variables and quality of life in adults with cystic fibrosis","volume":"4","author":"Gee L","year":"2005","unstructured":"Gee L, Abbott J, Hart A, Conway SP, Etherington C, Webb AK. Associations between clinical variables and quality of life in adults with cystic fibrosis. J Cyst Fibros. 2005, 4:59-66. 10.1016\/j.jcf.2004.12.005","journal-title":"J Cyst Fibros"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2474","article-title":"The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis","volume":"132","author":"Riekert KA","year":"2007","unstructured":"Riekert KA, Bartlett SJ, Boyle MP, Krishnan JA, Rand CS. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest. 2007, 132:231-237. 10.1378\/chest.06-2474","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.9.727","article-title":"Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity?","volume":"53","author":"Staab D","year":"1998","unstructured":"Staab D, Wenninger K, Gebert N, et al.. Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity?. Thorax. 1998, 53:727-731. 10.1136\/thx.53.9.727","journal-title":"Thorax"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.4.2347","article-title":"Development and validation of the Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis","volume":"128","author":"Quittner AL","year":"2005","unstructured":"Quittner AL, Buu A, Messer MA, Modi AC, Watrous M. Development and validation of the Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest. 2005, 128:2347-2354. 10.1378\/chest.128.4.2347","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.11.946","article-title":"Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis","volume":"55","author":"Gee L","year":"2000","unstructured":"Gee L, Abbott J, Conway SP, Etherington C, Webb AK. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax. 2000, 55:946-954. 10.1136\/thorax.55.11.946","journal-title":"Thorax"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.1.42","article-title":"Questions on life satisfaction for adolescents and adults with cystic fibrosis: development of a disease-specific questionnaire","volume":"123","author":"Goldbeck L","year":"2003","unstructured":"Goldbeck L, Schmitz TG, Henrich G, Herschbach P. Questions on life satisfaction for adolescents and adults with cystic fibrosis: development of a disease-specific questionnaire. Chest. 2003, 123:42-48. 10.1378\/chest.123.1.42","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins MR","year":"2006","unstructured":"Elkins MR, Robinson M, Rose BR, et al.. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med. 2006, 354:229-240. 10.1056\/NEJMoa043900","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200712-1804OC","article-title":"Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis","volume":"178","author":"McCoy KS","year":"2008","unstructured":"McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB. Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. Am J Respir Crit Care Med. 2008, 178:921-928. 10.1164\/rccm.200712-1804OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-3-19","article-title":"Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review","volume":"3","author":"Abbott J","year":"2005","unstructured":"Abbott J, Hart A. Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review. Health Qual Life Outcomes. 2005, 3:19. 10.1186\/1477-7525-3-19","journal-title":"Health Qual Life Outcomes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-2-66","article-title":"The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review","volume":"2","author":"Clarke SA","year":"2004","unstructured":"Clarke SA, Eiser C. The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review. Health Qual Life Outcomes. 2004, 2:66. 10.1186\/1477-7525-2-66","journal-title":"Health Qual Life Outcomes"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.5.751","article-title":"Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature","volume":"9","author":"Weiner JR","year":"2008","unstructured":"Weiner JR, Toy EL, Sacco P, Duh MS. Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature. Expert Opin Pharmacother. 2008, 9:751-766. 10.1517\/14656566.9.5.751","journal-title":"Expert Opin Pharmacother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-116","article-title":"Special considerations for patients with cystic fibrosis undergoing lung transplantation","volume":"131","author":"Hadjiliadis D","year":"2007","unstructured":"Hadjiliadis D. Special considerations for patients with cystic fibrosis undergoing lung transplantation. Chest. 2007, 131:1224-1231. 10.1378\/chest.06-116","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2014.11.006","article-title":"Costs and health-related quality of life of patients with cystic fibrosis and their carers in France","volume":"14","author":"Chevreul K","year":"2015","unstructured":"Chevreul K, Berg Brigham K, Michel M, Rault G. Costs and health-related quality of life of patients with cystic fibrosis and their carers in France. J Cyst Fibros. 2015, 14:384-391. 10.1016\/j.jcf.2014.11.006","journal-title":"J Cyst Fibros"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462306051476","article-title":"Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France","volume":"22","author":"Horvais V","year":"2006","unstructured":"Horvais V, Touzet S, Fran\u00e7ois S, Bourdy S, Bellon G, Colin C, Durieu I. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France. Int J Technol Assess Health Care. 2006, 22:525-531. 10.1017\/S0266462306051476","journal-title":"Int J Technol Assess Health Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2008.02.004","article-title":"Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network","volume":"7","author":"Huot L","year":"2008","unstructured":"Huot L, Durieu I, Bourdy S, Ganne C, Bellon G, Colin C, Touzet S. Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network. J Cyst Fibros. 2008, 7:403-408. 10.1016\/j.jcf.2008.02.004","journal-title":"J Cyst Fibros"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21441","article-title":"Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007","volume":"46","author":"Briesacher BA","year":"2011","unstructured":"Briesacher BA, Quittner AL, Fouayzi H, Zhang J, Swensen A. Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007. Pediatr Pulmonol. 2011, 46:770-776. 10.1002\/ppul.21441","journal-title":"Pediatr Pulmonol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/JTN.0000000000000042","article-title":"Health-related quality of life and rehabilitation cost following intensive care unit stay in multiple trauma patients","volume":"21","author":"Stergiannis P","year":"2014","unstructured":"Stergiannis P, Katsoulas T, Fildissis G, et al.. Health-related quality of life and rehabilitation cost following intensive care unit stay in multiple trauma patients. J Trauma Nurs. 2014, 21:115-121. 10.1097\/JTN.0000000000000042","journal-title":"J Trauma Nurs"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-004-6014-y","article-title":"Validating and norming of the Greek SF-36 Health Survey","volume":"14","author":"Pappa E","year":"2005","unstructured":"Pappa E, Kontodimopoulos N, Niakas D. Validating and norming of the Greek SF-36 Health Survey. Qual Life Res. 2005, 14:1433-1438. 10.1007\/s11136-004-6014-y","journal-title":"Qual Life Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.5603\/PiAP.2016.0025","article-title":"Quality of life in adults with cystic fibrosis: the Greek experience","volume":"84","author":"Stofa M","year":"2016","unstructured":"Stofa M, Xanthos T, Ekmektzoglou K, Chalkias A, Barouxis D, Pantazopoulos I, Iacovidou N. Quality of life in adults with cystic fibrosis: the Greek experience. Pneumonol Alergol Pol. 2016, 84:205-211. 10.5603\/PiAP.2016.0025","journal-title":"Pneumonol Alergol Pol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2165\/11588870-000000000-00000","article-title":"Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre","volume":"30","author":"Heimeshoff M","year":"2012","unstructured":"Heimeshoff M, Hollmeyer H, Schrey\u00f6gg J, Tiemann O, Staab D. Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre. Pharmacoeconomics. 2012, 30:763-777. 10.2165\/11588870-000000000-00000","journal-title":"Pharmacoeconomics"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.11.027","article-title":"Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial","volume":"15","author":"Dewitt EM","year":"2012","unstructured":"Dewitt EM, Grussemeyer CA, Friedman JY, Dinan MA, Lin L, Schulman KA, Reed SD. Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial. Value Health. 2012, 15:277-283. 10.1016\/j.jval.2011.11.027","journal-title":"Value Health"},{"key":"ref27","article-title":"CFQoL questionnaire as an assessment tool of quality of life in patients with cystic fibrosis [Article in Polish]","volume":"23","author":"Debska G","year":"2007","unstructured":"Debska G, Mazurek H. CFQoL questionnaire as an assessment tool of quality of life in patients with cystic fibrosis [Article in Polish]. Pol Merkur Lekarski. 2007, 23:137-140.","journal-title":"Pol Merkur Lekarski"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/265831-the-impact-of-cost-of-living-on-the-quality-of-life-of-cystic-fibrosis-patients-a-study-in-greece","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T07:46:35Z","timestamp":1719215195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/265831-the-impact-of-cost-of-living-on-the-quality-of-life-of-cystic-fibrosis-patients-a-study-in-greece"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.63009","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,24]]}}}